Growth Metrics

Plus Therapeutics (PSTV) Short-term Investments (2024 - 2025)

Plus Therapeutics has reported Short-term Investments over the past 2 years, most recently at $4.4 million for Q4 2025.

  • Quarterly Short-term Investments rose 23.4% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, up 23.4% year-over-year, with the annual reading at $4.4 million for FY2025, 23.4% up from the prior year.
  • Short-term Investments was $4.4 million for Q4 2025 at Plus Therapeutics, up from $3.3 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $4.6 million in Q2 2025 and troughed at $323000.0 in Q1 2024.